Recent publications by Researchers affiliated with the Centre for Tropical Medicine and Global Health
Identification of immune correlates of fatal outcomes in critically ill COVID-19 patients.
Youngs J. et al, (2021), PLoS Pathog, 17
Two doses of SARS-CoV-2 vaccination induce robust immune responses to emerging SARS-CoV-2 variants of concern.
Skelly DT. et al, (2021), Nature communications, 12
Equity for excellence in academic institutions: a manifesto for change
Wedekind L. et al, (2021), Wellcome Open Research, 6, 142 - 142
Author Correction: T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial
Ewer KJ. et al, (2021), Nature Medicine, 27, 1116 - 1116
A blood atlas of COVID-19 defines hallmarks of disease severity and specificity
Ahern DJ. et al, (2021)
T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses.
Ogbe A. et al, (2021), Nature communications, 12
A haemagglutination test for rapid detection of antibodies to SARS-CoV-2.
Townsend A. et al, (2021), Nature communications, 12
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials
Voysey M. et al, (2021), The Lancet, 397, 881 - 891
Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera
Zhou D. et al, (2021), Cell
Hepcidin-Mediated Hypoferremia Disrupts Immune Responses to Vaccination and Infection
Frost JN. et al, (2021), Med, 2, 164 - 179.e12
Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses
Barrett JR. et al, (2021), Nature Medicine, 27, 279 - 288
Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera
Supasa P. et al, (2021), Cell
Role of Burkholderia pseudomallei-Specific IgG2 in Adults with Acute Melioidosis, Thailand.
Chaichana P. et al, (2021), Emerging infectious diseases, 27, 463 - 470
T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial
Ewer KJ. et al, (2021), Nature Medicine, 27, 270 - 278
Mapping routine measles vaccination in low- and middle-income countries
(2021), Nature, 589, 415 - 419
Equity for excellence in academic institutions: a manifesto for change.
Wedekind L. et al, (2021), Wellcome open research, 6
Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
Voysey M. et al, (2021), The Lancet, 397, 99 - 111
Drug-resistant enteric fever worldwide, 1990 to 2018: a systematic review and meta-analysis
Browne AJ. et al, (2020), BMC Medicine, 18